Sight Sciences (SGHT) Stock Forecast, Price Target & Predictions
SGHT Stock Forecast
Sight Sciences stock forecast is as follows: an average price target of $7.50 (represents a 110.67% upside from SGHT’s last price of $3.56) and a rating consensus of 'Hold', based on 7 wall street analysts offering a 1-year stock forecast.
SGHT Price Target
The average price target for Sight Sciences (SGHT) is $7.50 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $5.00. This represents a potential 110.67% upside from SGHT's last price of $3.56.
SGHT Analyst Ratings
According to 7 Wall Street analysts, Sight Sciences's rating consensus is 'Hold'. The analyst rating breakdown for SGHT stock is 0 'Strong Buy' (0.00%), 2 'Buy' (28.57%), 5 'Hold' (71.43%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Sight Sciences Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 04, 2024 | Frank Takkinen | Loop Capital Markets | $5.00 | $4.66 | 7.30% | 40.45% |
| Oct 04, 2024 | Frank Takkinen | Loop Capital Markets | $10.00 | $5.81 | 72.12% | 180.90% |
| Aug 21, 2024 | Frank Takkinen | Lake Street | $10.00 | $6.08 | 64.47% | 180.90% |
| May 03, 2024 | Matt O'Brien | Piper Sandler | $6.00 | $5.70 | 5.26% | 68.54% |
| Dec 12, 2022 | Citigroup | $15.00 | $12.65 | 18.58% | 321.35% | |
| Aug 11, 2022 | Matt O'Brien | Piper Sandler | $15.00 | $9.81 | 52.91% | 321.35% |
The latest Sight Sciences stock forecast, released on Nov 04, 2024 by Frank Takkinen from Loop Capital Markets, set a price target of $5.00, which represents a 7.30% increase from the stock price at the time of the forecast ($4.66), and a 40.45% increase from SGHT last price ($3.56).
Sight Sciences Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 4 |
| Avg Price Target | - | $7.50 | $7.75 |
| Last Closing Price | $3.56 | $3.56 | $3.56 |
| Upside/Downside | -100.00% | 110.67% | 117.70% |
In the current month, the average price target of Sight Sciences stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Sight Sciences's last price of $3.56. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 04, 2024 | Lake Street | Buy | Buy | Downgrade |
| Oct 04, 2024 | Lake Street | Buy | Buy | Hold |
| Aug 21, 2024 | Lake Street | Buy | Initialise | |
| Jul 15, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Jul 10, 2024 | Citigroup | Neutral | Neutral | Hold |
| May 03, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Sep 12, 2023 | William Blair | Market Perform | Downgrade | |
| Sep 12, 2023 | Piper Sandler | Overweight | Neutral | Downgrade |
| Jan 06, 2023 | Stifel Nicolaus | Buy | Upgrade | |
| Dec 12, 2022 | Citigroup | Buy | Buy | Hold |
| Oct 11, 2022 | Morgan Stanley | Overweight | Overweight | Hold |
| Oct 05, 2022 | Needham | Hold | Initialise | |
| Aug 11, 2022 | Piper Sandler | Overweight | Overweight | Hold |
Sight Sciences's last stock rating was published by Lake Street on Nov 04, 2024. The company gave SGHT a "Buy" rating, the same as its previous rate.
Sight Sciences Financial Forecast
Sight Sciences Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $18.75M | $20.01M | $23.47M | $18.82M | $20.54M | $18.68M | $17.23M | $14.88M | $14.69M | $13.10M | $12.54M |
| Avg Forecast | $26.62M | $24.47M | $25.77M | $21.95M | $23.40M | $22.14M | $22.30M | $19.83M | $20.27M | $20.40M | $21.34M | $18.40M | $18.95M | $21.59M | $22.40M | $18.87M | $20.26M | $17.68M | $16.21M | $13.28M | $14.17M | $12.07M | $12.48M |
| High Forecast | $27.42M | $25.21M | $26.54M | $22.61M | $24.10M | $22.80M | $22.97M | $20.29M | $20.87M | $20.52M | $21.34M | $18.40M | $20.39M | $21.59M | $23.07M | $19.44M | $20.87M | $17.68M | $16.21M | $13.28M | $14.17M | $12.07M | $12.48M |
| Low Forecast | $26.08M | $23.98M | $25.25M | $21.50M | $22.92M | $21.69M | $21.85M | $19.52M | $19.59M | $20.28M | $21.34M | $18.40M | $17.50M | $21.59M | $21.95M | $18.49M | $19.85M | $17.68M | $16.21M | $13.28M | $14.17M | $12.07M | $12.48M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 5 | 4 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.93% | 1.05% | 1.00% | 1.01% | 1.06% | 1.06% | 1.12% | 1.04% | 1.09% | 1.00% |
Sight Sciences's average Quarter revenue forecast for Mar 24 based on 1 analysts is $18.40M, with a low forecast of $18.40M, and a high forecast of $18.40M. SGHT's average Quarter revenue forecast represents a -1.89% decrease compared to the company's last Quarter revenue of $18.75M (Dec 23).
Sight Sciences EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 5 | 4 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-10.92M | $-13.41M | $-13.40M | $-15.78M | $-15.67M | $-20.90M | $-22.57M | $-22.03M | $-27.73M | $-15.41M | $-16.36M |
| Avg Forecast | $-24.54M | $-22.56M | $-23.76M | $-20.23M | $-21.57M | $-20.41M | $-20.56M | $-18.28M | $-18.69M | $-18.81M | $-19.68M | $-16.96M | $-17.47M | $-19.90M | $-20.65M | $-17.40M | $-18.68M | $-16.62M | $-15.24M | $-12.48M | $-13.32M | $-11.35M | $-14.73M |
| High Forecast | $-24.05M | $-22.10M | $-23.28M | $-19.82M | $-21.13M | $-20.00M | $-20.14M | $-18.00M | $-18.06M | $-18.70M | $-19.68M | $-16.96M | $-16.13M | $-19.90M | $-20.23M | $-17.04M | $-18.30M | $-16.62M | $-15.24M | $-12.48M | $-13.32M | $-11.35M | $-11.78M |
| Low Forecast | $-25.28M | $-23.24M | $-24.47M | $-20.84M | $-22.22M | $-21.02M | $-21.18M | $-18.71M | $-19.24M | $-18.91M | $-19.68M | $-16.96M | $-18.80M | $-19.91M | $-21.27M | $-17.92M | $-19.24M | $-16.62M | $-15.24M | $-12.48M | $-13.32M | $-11.35M | $-17.67M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.63% | 0.67% | 0.65% | 0.91% | 0.84% | 1.26% | 1.48% | 1.76% | 2.08% | 1.36% | 1.11% |
undefined analysts predict SGHT's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Sight Sciences's previous annual EBITDA (undefined) of $NaN.
Sight Sciences Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 5 | 4 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-10.69M | $-13.04M | $-14.75M | $-17.07M | $-16.91M | $-22.23M | $-23.84M | $-23.26M | $-20.08M | $-17.17M | $-17.61M |
| Avg Forecast | $-8.29M | $-7.68M | $-7.60M | $-6.43M | $-10.04M | $-11.30M | $-10.61M | $-10.75M | $-11.17M | $-10.45M | $-14.92M | $-13.90M | $-15.98M | $-16.00M | $-17.20M | $-19.71M | $-21.00M | $-22.86M | $-23.15M | $-20.04M | $-19.54M | $-13.13M | $-15.86M |
| High Forecast | $-8.07M | $-7.48M | $-7.40M | $-6.26M | $-9.77M | $-11.00M | $-10.33M | $-6.35M | $-5.59M | $-10.17M | $-14.53M | $-13.53M | $-9.13M | $-15.58M | $-16.75M | $-19.19M | $-20.44M | $-22.86M | $-23.15M | $-20.04M | $-19.54M | $-13.13M | $-12.69M |
| Low Forecast | $-8.61M | $-7.98M | $-7.90M | $-6.68M | $-10.43M | $-11.74M | $-11.03M | $-14.17M | $-15.75M | $-10.86M | $-15.50M | $-14.44M | $-20.09M | $-16.63M | $-17.87M | $-20.48M | $-21.82M | $-22.86M | $-23.15M | $-20.04M | $-19.54M | $-13.13M | $-19.03M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.67% | 0.81% | 0.86% | 0.87% | 0.81% | 0.97% | 1.03% | 1.16% | 1.03% | 1.31% | 1.11% |
Sight Sciences's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. SGHT's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Sight Sciences SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 5 | 4 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $23.47M | $26.50M | $30.06M | $28.68M | $28.70M | $31.54M | $31.43M | $28.39M | $26.41M | $20.79M | $17.76M |
| Avg Forecast | $39.91M | $36.68M | $38.62M | $32.89M | $35.07M | $33.18M | $33.43M | $29.73M | $30.38M | $30.58M | $31.99M | $27.57M | $28.40M | $32.36M | $33.58M | $28.28M | $30.36M | $26.50M | $24.30M | $19.91M | $21.24M | $18.10M | $18.70M |
| High Forecast | $41.10M | $37.78M | $39.79M | $33.88M | $36.12M | $34.18M | $34.43M | $30.41M | $31.28M | $30.75M | $31.99M | $27.57M | $30.57M | $32.36M | $34.59M | $29.13M | $31.28M | $26.50M | $24.30M | $19.91M | $21.24M | $18.10M | $18.70M |
| Low Forecast | $39.10M | $35.94M | $37.84M | $32.23M | $34.36M | $32.51M | $32.75M | $29.27M | $29.36M | $30.40M | $31.99M | $27.57M | $26.23M | $32.36M | $32.90M | $27.71M | $29.75M | $26.50M | $24.30M | $19.91M | $21.24M | $18.10M | $18.70M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.83% | 0.82% | 0.90% | 1.01% | 0.95% | 1.19% | 1.29% | 1.43% | 1.24% | 1.15% | 0.95% |
Sight Sciences's average Quarter SG&A projection for Mar 24 is $27.57M, based on 1 Wall Street analysts, with a range of $27.57M to $27.57M. The forecast indicates a 17.50% rise compared to SGHT last annual SG&A of $23.47M (Dec 23).
Sight Sciences EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 5 | 4 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.22 | $-0.27 | $-0.30 | $-0.35 | $-0.35 | $-0.46 | $-0.50 | $-0.49 | $-0.42 | $-0.43 | $-0.42 |
| Avg Forecast | $-0.16 | $-0.15 | $-0.15 | $-0.13 | $-0.20 | $-0.22 | $-0.21 | $-0.21 | $-0.22 | $-0.21 | $-0.30 | $-0.28 | $-0.32 | $-0.32 | $-0.34 | $-0.39 | $-0.42 | $-0.46 | $-0.46 | $-0.40 | $-0.39 | $-0.26 | $-0.02 |
| High Forecast | $-0.16 | $-0.15 | $-0.15 | $-0.12 | $-0.19 | $-0.22 | $-0.21 | $-0.13 | $-0.11 | $-0.20 | $-0.29 | $-0.27 | $-0.18 | $-0.31 | $-0.33 | $-0.38 | $-0.41 | $-0.46 | $-0.46 | $-0.40 | $-0.39 | $-0.26 | $-0.02 |
| Low Forecast | $-0.17 | $-0.16 | $-0.16 | $-0.13 | $-0.21 | $-0.23 | $-0.22 | $-0.28 | $-0.31 | $-0.22 | $-0.31 | $-0.29 | $-0.40 | $-0.33 | $-0.35 | $-0.41 | $-0.43 | $-0.46 | $-0.46 | $-0.40 | $-0.39 | $-0.26 | $-0.02 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 0.85% | 0.88% | 0.89% | 0.84% | 1.00% | 1.08% | 1.22% | 1.07% | 1.63% | 18.95% |
According to undefined Wall Street analysts, Sight Sciences's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to SGHT previous annual EPS of $NaN (undefined).
Sight Sciences Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| RPID | Rapid Micro Biosystems | $1.06 | $8.00 | 654.72% | Hold |
| LUNG | Pulmonx | $6.13 | $13.00 | 112.07% | Buy |
| SGHT | Sight Sciences | $3.62 | $7.50 | 107.18% | Hold |
| KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
| CNMD | CONMED | $71.23 | $97.00 | 36.18% | Buy |
| OFIX | Orthofix Medical | $17.93 | $24.00 | 33.85% | |
| SIBN | SI-BONE | $13.84 | $18.50 | 33.67% | Buy |
| NPCE | NeuroPace | $11.52 | $15.00 | 30.21% | Buy |
| AVNS | Avanos Medical | $17.02 | $20.00 | 17.51% | Hold |
| VREX | Varex Imaging | $15.16 | $17.00 | 12.14% | Buy |
| FNA | Paragon 28 | $10.36 | $11.50 | 11.00% | Buy |
| CVRX | CVRx | $13.16 | $14.25 | 8.28% | Buy |
| AORT | Artivion | $28.90 | $30.75 | 6.40% | Buy |
| TCMD | Tactile Systems | $17.82 | $16.00 | -10.21% | Buy |